New evidence reveals adult human hearts can regrow muscle cells after myocardial infarction, opening new possibilities for ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has ...
- Reduced inflammation at the site of myocardial infarction and improved heart function demonstrated. Novel therapy to modulate immune response with apoptotic cell-derived nanovesicles. Myocardial ...
Background Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) carries high mortality. Early ...
Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.
News Medical on MSN
Scientists discover a non-classical platelet mechanism linked to severe infections
Platelets are small, anucleate blood cells that play an essential role in hemostasis. Their primary task is to recognize vascular injury, become activated, and aggregate via their surface receptor ...
Patients recently diagnosed with cancer show an increased risk for major bleeding after myocardial infarction, with the risk ...
Tirzepatide is noninferior to dulaglutide regarding composite of death from CV causes, myocardial infarction, or stroke.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results